Michael Pickup

Michael Pickup is an Associate Director at Novartis, where they apply expertise in cancer biology and the tumor microenvironment to uncover novel therapeutic opportunities for cancer treatment. With over seven years of experience, they have led research on the molecular mechanisms of tumor progression and responses to immunotherapy in solid tumors. Michael has contributed to several prestigious publications, including articles in *Nature Reviews Cancer* and *Cancer Research*, focusing on the tumor microenvironment and drug resistance. They have previously held positions at Bristol Myers Squibb, AbbVie, and the University of California, San Francisco, and completed a PhD in Cancer Biology at Vanderbilt University.